Valuation Collegium Pharmaceutical, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-12 EDT			5-day change	1st Jan Change
22.05 ^USD	-0.18%		+0.82%	-52.38%

09-23	Collegium's Durable Cash Flow From Pain Portfolio Poised to Support Further Business Development, Oppenheimer Says	MT
09-23	Oppenheimer Initiates Collegium Pharmaceutical at Outperform With $50 Price Target	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	650	778.9	1,004	924	1,464	717.9	-	-
Change	-	19.82%	28.87%	-7.95%	58.4%	-50.95%	-	-
Enterprise Value (EV) ¹	650	778.9	1,004	924	1,464	1,569	1,271	717.9
Change	-	19.82%	28.87%	-7.95%	58.4%	7.22%	-19.01%	-43.52%
P/E	10x	-31.4x	23.9x	15.4x	26.8x	13.6x	6.7x	5.17x
PBR	-	-	-	-	-	2.56x	2.02x	-
PEG	-	0x	-0x	0.3x	-3.83x	-2.08x	0x	0.2x
Capitalization / Revenue	2.35x	1.68x	1.77x	1.46x	1.88x	0.86x	0.85x	0.85x
EV / Revenue	2.35x	1.68x	1.77x	1.46x	1.88x	1.88x	1.51x	0.85x
EV / EBITDA	5.49x	2.93x	2.74x	2.3x	3.18x	3.45x	3.07x	1.92x
EV / EBIT	36.9x	23.4x	6.01x	5.44x	8.15x	3.5x	3.16x	1.91x
EV / FCF	-	-	3.66x	4.54x	4.47x	5.57x	3.54x	1.82x
FCF Yield	-	-	27.3%	22%	22.4%	17.9%	28.2%	55%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.86	-0.74	1.29	1.86	1.73	1.617	3.29	4.265
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	276.9	463.9	566.8	631.4	780.6	834	844.4	846.7
EBITDA ¹	118.3	266	367	401.2	460.5	454.7	413.7	373.1
EBIT ¹	17.63	33.32	167	169.9	179.6	448.9	402.1	376.5
Net income ¹	71.52	-25	48.16	69.19	62.87	41.98	88.33	159.7
Net Debt ¹	-	-	-	-	-	851.4	553.1	-
Reference price ²	18.68	23.20	30.78	28.65	46.30	22.05	22.05	22.05
Nbr of stocks (in thousands)	34,797	33,572	32,611	32,250	31,611	32,556	-	-
Announcement Date	2/24/22	2/23/23	2/22/24	2/27/25	2/26/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
COLLEGIUM PHARMACEUTICAL, INC.	13.64x	1.88x	3.45x	-	718M
ELI LILLY AND COMPANY	33.65x	12.2x	25.64x	0.58%	1,054B
JOHNSON & JOHNSON	29.26x	6.48x	18.46x	2.02%	636B
ABBVIE INC.	35.78x	8.25x	17.01x	2.47%	497B
MERCK & CO., INC.	111.13x	5.93x	25.32x	2.35%	359B
ROCHE HOLDING AG	19.43x	4.75x	11.8x	2.78%	345B
NOVARTIS AG	20.12x	5.29x	13.01x	3.01%	273B
ASTRAZENECA PLC	20.57x	4.22x	12.08x	2.1%	246B
AMGEN INC.	26.51x	6.86x	12.28x	2.42%	226B
GILEAD SCIENCES, INC.	-45.64x	6.72x	26.17x	2.19%	187B
Average	26.44x	6.26x	16.52x	2.21%	382.29B
Weighted average by Cap.	33.08x	7.88x	19.50x	1.89%